FDA approves Pfizer booster for kids ages 12-15

“Based on the FDA’s assessment of currently available data, a booster dose of the currently authorized vaccines may help provide better protection against both the delta and omicron variants,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement. “In particular, the omicron variant appears to be slightly more resistant to the antibody levels produced in response to the primary series doses from the current vaccines.